GATA3 and neuroblastoma: In this regard, the GATA3-specific deoxyribozyme (single-stranded synthetic DNA antisense molecules) that has been successfully applied to allergic asthma patients in recent phase 2a clinical trial may exert some efficacy against neuroblastoma [33].